PP_1170x120_10-25-21

Adam Bradbury

FDA new drug approvals down 16% in 2019, according to GlobalData

FDA new drug approvals down 16% in 2019, according to GlobalData

NEW YORK— In 2019 the U.S. Food and Drug Administration (FDA) accepted 119 New Drug Approvals (NDAs) and Biologics License Applications (BLAs) including New Molecular Entities (NMEs) and new formulations of older drugs. This figure represents a 3% increase over the 2014–2018 period average of 115 approvals, but is a 16% decrease on 2018’s 137

Adheris Health